NHEL) (the “Company” or “NHF Holdings”), announced that a letter from CEO, Vernon Tee to shareholders was published on October 14, 2019 about the temporary trading suspension by U.S Securities and Exchange Commission.
Dear Shareholders,
www.sec.gov). The temporary suspension of trading was pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange Act”), and terminated at 11:59 p.m. EDT on July 15, 2019. The Order alleged questions about the accuracy and adequacy of publicly disseminated information concerning, among other things, anticipated Natural Health Farm Holdings acquisitions.
www.nhf-holdings.com
Additionally, the Company discourages any and all promotional activity by non-company actors. Investors should not solely rely on third party newsletters/recommendations, websites or general stock symbols/classifications or other identifiers regarding our securities, whether positive or negative.
Our Board of Directors has reviewed all of our press releases issued over the past year and we believe that each press release accurately represented the facts as we know them on the date of publication. We remain committed to providing our shareholders with the most up to date, accurate and transparent.
www.finra.org), a governing organization for public listed companies trading on the over-the-counter-market.
We thank you for your continued support and will keep everyone informed on the progress.
here
NHEL) is a Nevada-based fully integrated nutraceutical biotechnology company, offering products and related services through healthcare practitioners and direct-to-consumers. NHEL began a global expansion strategy in 2018, announcing the acquisition of several established revenue generating companies focused on nutraceutical product research and development, manufacturing, quality control, marketing and distribution. The company now owns a research & development laboratory in Malaysia, franchisee management services company and an Australia manufacturing facility producing practitioner only naturopathic and homeopathic medicines.
www.nhf-holdings.com
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.